Oruka Therapeutics (ORKA) Held by Superinvestors
ORUKA THERAPEUTICS INC (ORKA) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $143.09M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Viking Global Investors is currently the largest disclosed institutional shareholder of ORKA tracked by InsiderSet, reporting ownership valued at approximately $143.09M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $111.98M, representing an estimated loss of -21.74% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed ORKA value among the investors covered in this analysis. Major shareholders include Viking Global Investors, and several other long-term asset managers with concentrated positions in ORUKA THERAPEUTICS INC (ORKA).
This page ranks the largest institutional ORKA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Viking Global Investors | Ole Andreas Halvorsen | 0.41% | 1,503,478 | $143,086,001 | $111,979,041 | -$31,106,960 | -21.74% |
Frequently asked questions about ORKA
Who are the largest superinvestors holding ORKA?
The largest superinvestors holding ORKA in the latest SEC Form 13F filings include Viking Global Investors. InsiderSet ranks these superinvestors by their latest reported ORKA position.
What does the ORKA superinvestors page include?
This page tracks ORKA positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. ORUKA THERAPEUTICS INC (ORKA) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold ORKA?
InsiderSet currently tracks 1 superinvestors reporting ORKA holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own ORKA.
How much ORKA stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $143.09M in ORKA holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were ORKA superinvestor holdings last updated?
The latest ORKA superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor ORKA holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its ORKA position after the reporting date.
Are superinvestors buying or selling ORKA?
Buying and selling can be analyzed by comparing ORKA positions across consecutive 13F reporting periods. InsiderSet's ORKA Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View ORKA ownership changes.
How have superinvestor ORKA holdings changed over time?
InsiderSet tracks ORKA holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.